NCT03577665

Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer

A Phase II Study of Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: National Cancer Center, Korea · Other Government
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Proton alone therapy is performed -\> 5 times a week, 7200 cGy / 15 fractions for 3 weeks total

Detailed description

This clinical trial is a prospective, single-organ, phase II clinical trial to evaluate the efficacy of curative proton therapy for liver metastasis of colorectal cancer diagnosed histologically as adenocarcinoma. Patients who meet the selection criteria should be selected, signed for consent, and treated 5 times a week for 7200 cGy / 15 fractions alone for 3 weeks.

Conditions

• Colorectal Cancer

Interventions

Type	Name	Description
RADIATION	curative proton therapy	Patients who meet the selection criteria are selected, signed for consent, and treated with proton therapy alone at 7200 cGy / 15 fractions, 5 times a week for 3 weeks

Timeline

• Start date: 2018-05-21
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2018-07-05
• Last updated: 2019-08-21

Locations

1 site across 1 country: South Korea